Hainan Shuangcheng Pharmaceuticals Co., Ltd.
SZSE:002693.SZ
6.85 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||
| Current Assets: | |||||||||||||||
| Cash & Cash Equivalents
| 3.387 | 12.197 | 21.618 | 5.797 | 42.675 | 68.086 | 31.713 | 24.979 | 246.235 | 85.396 | 346.758 | 446.761 | 33.588 | 149.831 | 9.929 |
| Short Term Investments
| 28.517 | 133.813 | 55.403 | 94.25 | 52.8 | 139.978 | 147.25 | 5 | 3.37 | 380 | 220 | 161 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 31.904 | 146.01 | 77.021 | 100.047 | 95.475 | 68.086 | 31.713 | 24.979 | 246.235 | 85.396 | 346.758 | 446.761 | 33.588 | 149.831 | 9.929 |
| Net Receivables
| 16.359 | 40.967 | 33.133 | 44.624 | 82.236 | 69.192 | 244.699 | 84.178 | 201.092 | 102.747 | 65.785 | 36.136 | 50.446 | 23.907 | 16.402 |
| Inventory
| 74.307 | 65.413 | 55.242 | 52.791 | 47.636 | 86.306 | 119.865 | 34.237 | 28.319 | 53.054 | 30.621 | 23.466 | 12.208 | 10.381 | 9.769 |
| Other Current Assets
| 0.196 | 0.005 | 0.054 | 0.039 | 0.039 | 148.562 | 161.658 | 8.021 | 3.37 | 380 | 220 | 161 | -0.756 | -2.487 | -4.282 |
| Total Current Assets
| 135.236 | 252.394 | 165.45 | 197.5 | 225.387 | 372.146 | 557.935 | 151.414 | 479.016 | 621.196 | 663.164 | 667.362 | 95.486 | 181.632 | 31.818 |
| Non-Current Assets: | |||||||||||||||
| Property, Plant & Equipment, Net
| 457.597 | 471.766 | 504.732 | 541.001 | 601.099 | 637.817 | 679.522 | 658.936 | 443.222 | 264.146 | 213.317 | 182.119 | 133.85 | 54.201 | 53.428 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 171.782 | 164.905 | 156.924 | 134.377 | 115.218 | 96.485 | 101.15 | 105.855 | 134.2 | 48.17 | 33.536 | 33.261 | 18.216 | 16.425 | 12.056 |
| Goodwill and Intangible Assets
| 171.782 | 164.905 | 156.924 | 134.377 | 115.218 | 96.485 | 101.15 | 105.855 | 134.2 | 48.17 | 33.536 | 33.261 | 18.216 | 16.425 | 12.056 |
| Long Term Investments
| 10 | 8.794 | 17.3 | 25.864 | 3.139 | 3.311 | 3.738 | 215.128 | 412.913 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 1.517 | 0.97 | 1.033 | 0.661 | 0.721 | 1.494 | 1.168 | 2.956 | 5.872 | 3.993 | 2.618 | 2.387 | 0.321 | 0.23 | 0.243 |
| Other Non-Current Assets
| 27.117 | 12.189 | 9.118 | 8.273 | 5.419 | 8.993 | 33.601 | 31.239 | 74.938 | 6.037 | 4.41 | 1.522 | 0.185 | 0.247 | 0.309 |
| Total Non-Current Assets
| 668.012 | 658.624 | 689.106 | 710.177 | 725.596 | 748.099 | 819.179 | 1,014.114 | 1,071.145 | 322.346 | 253.881 | 219.289 | 152.572 | 71.102 | 66.035 |
| Total Assets
| 803.248 | 911.019 | 854.556 | 907.677 | 950.983 | 1,120.246 | 1,377.114 | 1,165.528 | 1,550.161 | 943.542 | 917.045 | 886.651 | 248.058 | 252.735 | 97.853 |
| Liabilities & Equity: | |||||||||||||||
| Current Liabilities: | |||||||||||||||
| Account Payables
| 17.136 | 15.498 | 17.159 | 15.443 | 9.891 | 11.786 | 80.491 | 28.532 | 13.172 | 8.876 | 10.68 | 10.651 | 7.072 | 3.852 | 7.459 |
| Short Term Debt
| 10.051 | 205.303 | 0.25 | 55.657 | 0.26 | 2.326 | 45.617 | 190 | 345 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Payables
| 3.718 | 12.78 | 7.17 | 6.333 | 10.12 | 5.276 | 8.805 | 4.458 | 11.94 | 7.19 | 8.316 | 6.658 | 3.997 | 4.537 | 4.547 |
| Deferred Revenue
| 110.718 | 24.953 | 89.183 | 56.848 | 70.089 | 14.359 | 4.886 | 31.535 | 83.122 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 2.037 | 73.608 | 1.819 | 1.461 | 13.34 | 78.364 | 69.625 | 5.025 | 3.372 | 13.802 | 18.31 | 14.292 | 10.655 | 89.263 | 10.648 |
| Total Current Liabilities
| 139.942 | 319.362 | 108.412 | 129.409 | 93.58 | 106.835 | 200.62 | 255.092 | 444.667 | 22.678 | 28.99 | 24.942 | 17.727 | 93.116 | 18.107 |
| Non-Current Liabilities: | |||||||||||||||
| Long Term Debt
| 135 | 0 | 167 | 167 | 167 | 306 | 367 | 297 | 145 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 8.027 | 7.636 | 8.867 | 10.253 | 10.538 | 31.117 | 32.754 | 33.796 | 31.986 | 26.579 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 2.633 | 3.079 | 3.527 | 2.704 | 1.603 | 0.878 | 1.071 | 1.108 | 0.903 | 0.731 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 5.729 | 13.963 | 25.405 | 0 | 0 | 17.434 | 15.86 | 2.1 | 1.8 | 1.8 |
| Total Non-Current Liabilities
| 145.66 | 10.715 | 179.393 | 179.957 | 179.141 | 343.724 | 414.789 | 357.309 | 177.889 | 27.31 | 17.434 | 15.86 | 2.1 | 1.8 | 1.8 |
| Total Liabilities
| 285.603 | 330.076 | 287.805 | 309.366 | 272.721 | 450.559 | 615.408 | 612.4 | 622.556 | 49.988 | 46.424 | 40.802 | 19.827 | 94.916 | 19.907 |
| Equity: | |||||||||||||||
| Preferred Stock
| 34.425 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock
| 416.729 | 414.737 | 412 | 405 | 405 | 405 | 405 | 405 | 419.186 | 270 | 180 | 120 | 90 | 90 | 5 |
| Retained Earnings
| -346.959 | -296.218 | -305.23 | -284.633 | -231.304 | -255.96 | -186.504 | -192.819 | 195.592 | 174.13 | 157.056 | 138.923 | 77.701 | 14.305 | 65.778 |
| Accumulated Other Comprehensive Income/Loss
| -0.351 | 87.167 | 82.181 | 86.031 | 86.032 | 86.486 | 86.374 | 54.42 | 40.487 | -0 | -0 | 0 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 367.642 | 307.862 | 292.897 | 286.527 | 286.527 | 286.527 | 286.527 | 286.527 | 272.342 | 449.424 | 533.564 | 586.926 | 60.53 | 53.514 | 7.168 |
| Total Shareholders Equity
| 471.486 | 513.548 | 481.848 | 492.925 | 546.255 | 522.053 | 591.397 | 553.128 | 927.605 | 893.554 | 870.621 | 845.849 | 228.231 | 157.819 | 77.946 |
| Total Equity
| 517.646 | 580.942 | 566.751 | 598.312 | 678.262 | 669.687 | 761.706 | 553.128 | 927.605 | 893.554 | 870.621 | 845.849 | 228.231 | 157.819 | 77.946 |
| Total Liabilities & Shareholders Equity
| 803.248 | 911.019 | 854.556 | 907.677 | 950.983 | 1,120.246 | 1,377.114 | 1,165.528 | 1,550.161 | 943.542 | 917.045 | 886.651 | 248.058 | 252.735 | 97.853 |